Severe Strongyloidiasis: a Systematic Review of Case Reports

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2013 Feb 12

PMID 23394259

Citations 147

Authors

Dora Buonfrate

Ana Requena-Mendez

Andrea Angheben

Jose Munoz

Federico Gobbi

Jef van den Ende

Zeno Bisoffi

Affiliations

Soon will be listed here.

Abstract

Background: Strongyloidiasis is commonly a clinically unapparent, chronic infection, but immuno suppressed subjects can develop fatal disease. We carried out a review of literature on hyperinfection syndrome (HS) and disseminated strongyloidiasis (DS), in order to describe the most challenging aspects of severe strongyloidiasis.

Methods: We conducted a structured search using PubMed to collect case reports and short case series on HS/DS published from 1991 to 2011. We restricted search to papers in English, Spanish, Italian and French. Case reports were classified as HS/DS according to given definitions.

Results: Records screened were 821, and 311 were excluded through titles and abstract evaluation. Of 510 full-text articles assessed for eligibility, 213 were included in qualitative analysis. As some of them were short case series, eventually the number of cases analyzed was 244.Steroids represented the main trigger predisposing to HS and DS (67% cases): they were mostly administered to treat underlying conditions (e.g. lymphomas, rheumatic diseases). However, sometimes steroids were empirically prescribed to treat signs and symptoms caused by unsuspected/unrecognized strongyloidiasis. Diagnosis was obtained by microscopy examination in 100% cases, while serology was done in a few cases (6.5%). Only in 3/29 cases of solid organ/bone marrow transplantation there is mention of pre-transplant serological screening. Therapeutic regimens were different in terms of drugs selection and combination, administration route and duration. Similar fatality rate was observed between patients with DS (68.5%) and HS (60%).

Conclusions: Proper screening (which must include serology) is mandatory in high - risk patients, for instance candidates to immunosuppressive medications, currently or previously living in endemic countries. In some cases, presumptive treatment might be justified. Ivermectin is the gold standard for treatment, although the optimal dosage is not clearly defined in case of HS/DS.

Citing Articles

IgE and Eosinophilia in Newly Arrived Refugees in Denmark: A Cross-Sectional Study of Prevalence and Clinical Management in Primary Care.

Lanng K, Margolinsky R, Wejse C, Kallestrup P, Hvass A Int J Environ Res Public Health. 2025; 22(2).

PMID: 40003407 PMC: 11855504. DOI: 10.3390/ijerph22020180.

Thermosensory behaviors of the free-living life stages of Strongyloides species support parasitism in tropical environments.

Gregory B, Desouky M, Slaughter J, Hallem E, Bryant A PLoS Negl Trop Dis. 2024; 18(12):e0012529.

PMID: 39689121 PMC: 11687888. DOI: 10.1371/journal.pntd.0012529.

Review of the WHO guideline on preventive chemotherapy for public health control of strongyloidiasis.

Lo N, Addiss D, Buonfrate D, Amor A, Anegagrie M, Bisoffi Z Lancet Infect Dis. 2024; 25(3):e146-e152.

PMID: 39481419 PMC: 11871984. DOI: 10.1016/S1473-3099(24)00595-4.

Thermosensory behaviors of the free-living life stages of species support parasitism in tropical environments.

Gregory B, Desouky M, Slaughter J, Hallem E, Bryant A bioRxiv. 2024; .

PMID: 39314377 PMC: 11419086. DOI: 10.1101/2024.09.12.612595.

Feline strongyloidiasis: An insight into its global prevalence and transmission cycle.

Zhao H, Bradbury R One Health. 2024; 19:100842.

PMID: 39026543 PMC: 11255105. DOI: 10.1016/j.onehlt.2024.100842.

References

Adetiloye V . A case of fatal gastrointestinal strongyloidiasis in an otherwise healthy Nigerian, masquerading as gastric outlet obstruction. Trop Geogr Med. 1992; 44(1-2):60-2. View

Gulbas Z, Kebapci M, Pasaoglu O, Vardareli E . Successful ivermectin treatment of hepatic strongyloidiasis presenting with severe eosinophilia. South Med J. 2004; 97(9):907-10. DOI: 10.1097/01.SMJ.0000139936.20116.A7. View

Ho P, Luk W, Chan A, Yuen K . Two cases of fatal strongyloidiasis in Hong Kong. Pathology. 1997; 29(3):324-6. DOI: 10.1080/00313029700169215. View

Lambroza A, Dannenberg A . Eosinophilic ascites due to hyperinfection with Strongyloides stercoralis. Am J Gastroenterol. 1991; 86(1):89-91. View

van Hattem S, Schuttelaar M . Disseminated strongyloidiasis caused by heart donor-to-host transmission presenting with purpura. Clin Exp Dermatol. 2009; 35(4):e149-50. DOI: 10.1111/j.1365-2230.2009.03740.x. View

Davidson R . Infection due to Strongyloides stercoralis in patients with pulmonary disease. South Med J. 1992; 85(1):28-31. DOI: 10.1097/00007611-199201000-00008. View

Celedon J, Fox J, Garcia R, Wiest P . Systemic strongyloidiasis in patients infected with the human immunodeficiency virus. A report of 3 cases and review of the literature. Medicine (Baltimore). 1994; 73(5):256-63. DOI: 10.1097/00005792-199409000-00004. View

Csermely L, Jaafar H, Kristensen J, Castella A, Gorka W, Chebli A . Strongyloides hyper-infection causing life-threatening gastrointestinal bleeding. World J Gastroenterol. 2006; 12(39):6401-4. PMC: 4088155. DOI: 10.3748/wjg.v12.i39.6401. View

Williams B . Disseminated strongyloidiasis in a World War II Veteran with metastatic undifferentiated carcinoma of neuroendocrine type. South Med J. 1992; 85(10):1023-6. DOI: 10.1097/00007611-199210000-00025. View

10.

Rojo-Marcos G, Cuadros-Gonzalez J, Gonzalez-Juarez M, Gomez-Ayerbe C . [Strongyloides stercoralis hyperinfection syndrome in a Colombian patient receiving immunosuppressive treatment]. Enferm Infecc Microbiol Clin. 2009; 27(7):432-4. DOI: 10.1016/j.eimc.2008.11.015. View

11.

Chiu H, Lai S . Fatal meningoencephalitis caused by disseminated strongyloidiasis. Acta Neurol Taiwan. 2005; 14(1):24-7. View

12.

Aregawi D, Lopez D, Wick M, Scheld W, Schiff D . Disseminated strongyloidiasis complicating glioblastoma therapy: a case report. J Neurooncol. 2009; 94(3):439-43. DOI: 10.1007/s11060-009-9878-4. View

13.

Galimberti R, Ponton A, Zaputovich F, Velasquez L, Galimberti G, Torre A . Disseminated strongyloidiasis in immunocompromised patients--report of three cases. Int J Dermatol. 2009; 48(9):975-8. DOI: 10.1111/j.1365-4632.2009.04082.x. View

14.

Ghoshal U, Saha J, Ghoshal U, Ray B, Santra A, Naik S . Pigmented nails and Strongyloides stercoralis infestation causing clinical worsening in a patient treated for immunoproliferative small intestinal disease: two unusual observations. J Diarrhoeal Dis Res. 2000; 17(1):43-5. View

15.

Lim L, Biggs B . Fatal disseminated strongyloidiasis in a previously treated patient. Med J Aust. 2001; 174(7):355-6. DOI: 10.5694/j.1326-5377.2001.tb143315.x. View

16.

Agarwal V, Khurana H, Le H, Mathisen G, Kamangar N . 30-year-old HIV-positive female with diffuse alveolar hemorrhage. J Intensive Care Med. 2009; 24(3):200-4. DOI: 10.1177/0885066609332583. View

17.

El Masry H, ODonnell J . Fatal stongyloides hyperinfection in heart transplantation. J Heart Lung Transplant. 2005; 24(11):1980-3. DOI: 10.1016/j.healun.2005.04.005. View

18.

Al Maslamani M, Al Soub H, Al Khal A, Al Bozom I, Abu Khattab M, Chacko K . Strongyloides stercoralis hyperinfection after corticosteroid therapy: a report of two cases. Ann Saudi Med. 2009; 29(5):397-401. PMC: 2860402. DOI: 10.4103/0256-4947.55172. View

19.

Schindzielorz A, Edberg S, Bia F . Strongyloides stercoralis hyperinfection and central nervous system involvement in a patient with relapsing polychondritis. South Med J. 1991; 84(8):1055-7. DOI: 10.1097/00007611-199108000-00030. View

20.

Mizuno S, Iida T, Zendejas I, Martin T, Schain D, Turner B . Strongyloides hyperinfection syndrome following simultaneous heart and kidney transplantation. Transpl Int. 2008; 22(2):251-3. DOI: 10.1111/j.1432-2277.2008.00767.x. View